Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,190 GBX | +1.35% | -0.86% | +15.00% |
Jun. 02 | Astra's Enhertu breast cancer trial shows 'unprecedented' results | RE |
Jun. 02 | Astra's Enhertu delays breast cancer in patients with low HER2 levels | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.00% | 240B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Ordered to Pay $108 Million to Pfizer for Patent Violations